Blockade of NF-κB nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 432-436

  Li, Zhi Min ^a   Pu, Yu Wei ^b   Zhu, Bao Song ^b  

^a NANTONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Gastric cancer; Invasiveness; NF B p65; SN50

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; SN 50; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

EID: 84879478849     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1390     Document Type: Article

References (34)

1. Xing CG, Zhu BS, Liu HH, Lin F, Yao HH, Liang ZQ and Qin ZH: LY294002 induces p53-dependent apoptosis of SGC7901 gastric cancer cells. Acta Pharmacol Sin 29: 489-498, 2008.
2. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H and Chen GH: Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol 11: 3197-3203, 2005.
3. Fernandez HA, Kallenbach K, Seghezzi G, Grossi E, Colvin S, Schneider R, Mignatti P and Galloway A: Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1. J Surg Res 82: 156-162, 1999.
4. Lazǎr D, Tǎban S, Raica M, Sporea I, Cornianu M, Goldiş A and Vernic C: Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers. Rom J Morphol Embryol 49: 137-48, 2008.
5. Wang J, Tian XF, Wang S, Ma LF and Yao JH: Correlation between expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and angiogenesis in gastric cancer. Chin J Cancer Res 17: 283-287, 2005.
6. Sun WH, Sun YL, Fang RN, Shao Y, Xu HC, Xue QP, DingGX and Cheng YL: Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 35: 707-713, 2005.
7. Gerber HP and Ferrara N: The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med (Berl) 81: 20-31, 2003.
8. Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F and Dammacco F: A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica 88: 176-185, 2003.
9. Hall PA, Levison DA, Woods AL, et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
10. Luque I and Gélinas C: Rel/NF-kappa B and I kappa B factors in oncogenesis. Semin Cancer Biol 8: 103-111, 1997.
11. Haerslev T and Jacobsen GK. Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors. Virchows Arch 424: 39-46, 1994.
12. Jónsson ZO and Hübscher U: Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. Bioessays 19: 967-975, 1997.
13. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest107, 241-246, 2001.
14. Zhu B, Xing C, Lin F, Fan X, Zhao K and Qin Z: Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis. World J Gastroenterol 17: 478-487, 2011.
15. Zhou HB, Chen JM, Cai JT, Du Q and Wu CN: Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J Gastroenterol 14: 627-631, 2008.
16. Wang CY, Guttridge DC, Mayo MW and Baldwin AS Jr: NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol19: 5923-5929, 1999.
17. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
18. Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC and TreonSP: Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood 99: 2162-2171, 2002.
19. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
20. Kabashima A, Yao T, Sugimachi K and Tsuneyoshi M: Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol 33: 80-86, 2002.
21. Cai H, Kong ZR and Chen HM: Matrix metalloproteinase-2 and angiogenesis in gastric cancer. Ai Zheng 21: 25-28, 2002 (InChinese).
22. Takahashi Y, Kitadai Y, Ellis LM, Bucana CD, Fidler IJ and Mai M: Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma. Jpn J Cancer Res 93: 1258-1265, 2002.
23. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-122, 1997.
24. Brand K: Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther 2: 255-271, 2002.
25. Jiang Y, Goldberg ID and Shi YE: Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-2252, 2002.
26. Chang C and Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol11: S37-S43, 2001.
27. Giannelli G and Antonaci S: Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol Histopathol 17: 339-345, 2002.
28. Yoon SO, Park SJ, Yun CH and Chung AS: Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. JBiochem Mol Biol 36: 128-137, 2003.
29. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, RoncaR, Tosatti MP and Presta M: Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162: 1913-1926, 2003.
30. Ferrara N: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29: 10-14, 2002.
31. Bellamy WT: Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol 28: 551-559, 2001.
32. Tian X, Song S, Wu J, Meng L, Dong Z and Shou C: Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun 286: 505-512, 2001.
33. Mao ZB, Xiao MB, Huang JF, Ni HB, Ni RZ, Wei Q and ZhangH: Expression of VEGF and its signification in serum of gastric cancer. Shijie Huaren Xiaohua Zazhi 10: 1220-1221, 2002.
34. Lou G, Gao Y, Ning XM and Zhang QF: Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor. World J Gastroenterol 11: 5032-5036, 2005.